Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol for Wheeze in Young Children
NCT04584034Phase 4Withdrawn
- Start
- Sep 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial comparing Salbutamol with Placebo (2 arms). Primary endpoint: Course of the parent reported respiratory symptom score at 5 days. Planned start Sep 2021; status: withdrawn.
02
Drugs
salbutamol
Beyond the preview
Go deeper on NCT04584034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04584034.